Genotoxic stress-induced nuclear localization of oncoprotein YB-1 in the absence of proteolytic processing

Oncogene

Volumn 29, Issue 3, 2010, Pages 403-410

  Cohen, S B ^a,b   Ma, W ^a   Valova, V A ^a   Algie, M ^c   Harfoot, R ^c   Woolley, A G ^c   Robinson, P J ^a,b   Braithwaite, A W ^a,b,c  

^a CHILDREN'S MEDICAL RESEARCH INSTITUTE   (Australia)

^b University of Sydney   (Australia)

^c UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Nuclear; Oncoprotein; Proteolysis; Translocation; YB 1

Indexed keywords

HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; PROTEASOME; Y BOX BINDING PROTEIN 1;

ARTICLE; BINDING AFFINITY; GENE ACTIVATION; GENETIC TRANSCRIPTION; GENOTOXICITY; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN LOCALIZATION; PROTEIN PURIFICATION; STRESS;

ACTIVE TRANSPORT, CELL NUCLEUS; ANTINEOPLASTIC AGENTS; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL NUCLEUS; CHROMATOGRAPHY, LIQUID; CISPLATIN; CYTOPLASM; DACTINOMYCIN; DNA DAMAGE; DNA-BINDING PROTEINS; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; NUCLEAR PROTEINS; NUCLEIC ACID SYNTHESIS INHIBITORS; PROTEIN TRANSPORT; RNA INTERFERENCE; TANDEM MASS SPECTROMETRY; TRANSCRIPTIONAL ACTIVATION; ULTRAVIOLET RAYS;

EID: 75149186861     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2009.321     Document Type: Article

References (20)

1. Asakuno K, Kohno K, Uchiumi T, Kubo T, Sato S, Isono M et al. (1994). Involvement of a DNA binding protein, MDR-NF1/YB-1, in human MDR1 gene expression by Actinomycin D. Biochem Biophys Res Comm 199: 1428-1435.
2. Bargou RC, Jurchott K, Wagener C, Bergmann S, Metzner S, Bommert K et al. (1997). Nuclear localization and increased levels of transcription factor YB-1 in primary human breast cancers are associated with intrinsic MDR1 gene expression. Nat Med 3: 447-450.
3. Berquin IM, Pang B, Dziubinski ML, Scott LM, Chen YQ, Nolan GP et al. (2005). Y-box-binding protein 1 confers EGF independence to human mammary epithelial cells. Oncogene 24: 3177-3186.
4. Chatterjee M, Rancso C, Stuhmer T, Eckstein N, Andrulis M, Gerecke C et al. (2008). The Y-box binding protein YB-1 is associated with progressive disease and mediates survival and drug resistance in multiple myeloma. Blood 111: 3714-3722.
5. Fujita T, Ito K, Izumi H, Kimura M, Sano M, Nakagomi H et al. (2005). Increased nuclear localization of transcription factor Y-box binding protein 1 accompanied by up-regulation of P-glycoprotein in breast cancer pretreated with paclitaxel. Clin Cancer Res 11: 8837-8844.
6. Gimenez-Bonafe P, Fedoruk MN, Whitmore TG, Akbari M, Ralph JL, Ettinger S et al. (2004). YB-1 is upregulated during prostate cancer tumor progression and increases P-glycoprotein activity. Prostate 59: 337-349.
7. Guay D, Evoy A, Paquet E, Garand C, Bachvarova M, Bachvarov D et al. (2008). The strand separation and nuclease activities associated with YB-1 are dispensable for cisplatin resistance but overexpression of YB-1 in MCF7 and MDA-MB-231 breast tumor cells generates several chemoresistance signatures. Intl J Biochem Cell Biol 40: 2492-2507.
8. Horwitz EM, Maloney KA, Ley TJ. (1994). A human protein containing a 'cold shock' domain binds specifically to H-DNA upstream from the human g-globin genes. J Biol Chem 269: 14130-14139.
9. Ito Y, Yoshida H, Shibahara K, Uruno T, Nakano K, Takamura Y et al. (2003). Y-box binding protein expression in thyroid neoplasms: its linkage with anaplastic transformation. Pathol Intl 53: 429-433.
10. Kohno K, Izumi H, Uchiumi T, Ashizuka M, Kuwano M. (2003). The pleiotropic functions of the Y-box-binding protein, YB-1. BioEssays 25: 691-698.
11. Lee SM, Dunnavant FD, Jang H, Zunt J, Levin MC. (2006). Autoantibodies that recognize functional domains of hnRNP A1 implicate molecular mimicry in the pathogenesis of neurological disease. Neurosci Lett 401: 188-193.
12. Oda Y, Sakamoto A, Shinohara N, Ohga T, Uchiumi T, Kohno K et al. (1998). Nuclear expression of YB-1 protein correlates with P-glycoprotein expression in human osteosarcoma. Clin Cancer Res 4: 2273-2277.
13. Oda Y, Ohishi Y, Saito T, Hinoshita E, Uchiumi T, Kinukawa N et al. (2003). Nuclear expression of Y-box binding protein-1 correlates with P-glycoprotein and topoisomerase II alpha expression, and with poor prognosis in synovial sarcoma. J Pathol 199: 251-258.
14. Ohga T, Koike K, Ono M, Makino Y, Itagaki Y, Tanimoto M et al. (1996). Role of the human Y box-binding protein YB-1 in cellular sensitivity to the DNA-damaging agents cisplatin, mitomycin C, and ultraviolet light. Cancer Res 56: 4224-4228.
15. Raffetseder U, Frye B, Rauen T, Jurchott K, Royer HD, Jansen PL et al. (2003). Splicing factor SRp30c interaction with Y-box protein-1 confers nuclear YB-1 shuttling and alternative splice site selection. J Biol Chem 278: 18241-18248.
16. Shibahara K, Sugio K, Osak T, Uchiumi T, Maehara Y, Kohno K et al. (2001). Nuclear expression of the Y-box binding protein, YB-1, as a novel marker of disease progression in non-small cell lung cancer. Clin Cancer Res 7: 3151-3155.
17. Sorokin AV, Selyutina AA, Skabkin MA, Guryanov SG, Nazimov IV, Richard C et al. (2005). Proteasome-mediated cleavage of the Y-box-binding protein 1 is linked to DNA-damage stress response. EMBO J 24: 3602-3612.
18. Stenina OI, Poptic EJ, DiCorleto PE. (2000). Thrombin activates a Y box-binding protein (DNA-binding protein B) in endothelial cells. J Clin Invest 106: 579-587.
19. Sutherland BW, Kucab J, Wu J, Lee C, Cheang M, Yorida E et al. (2005). Akt phosphorylates the Y-box binding protein 1 at Ser102 located in the cold shock domain and affects the anchorage-independent growth of breast cancer cells. Oncogene 24: 4281-4292.
20. Wolffe AP. (1994). Structural and functional properties of the evolutionarily ancient Y-box family of nucleic acid binding proteins. BioEssays 16: 245-251.